Medidata has entered a strategic collaboration with digital clinical solutions and services provider EDETEK for clinical trials and data management.

Under this partnership, the parties intend to provide comprehensive, end-to-end offerings for biopharmaceutical and medical device companies, as well as clinical research organisations in the biopharmaceutical sector.  

The enterprise-level collaboration guarantees integrated data management, improved technical capabilities, comprehensive biometrics solutions, and wider services. 

Medidata Rave EDC will be combined with EDETEK CONFORM to carry out the assessment, cleaning, and calibration of data.

The clinical informatics expertise of EDETEK will be merged with the technical expertise of Medidata to offer sector and industry-based capabilities to customers.

The companies will also design end-to-end biometrics and data science solutions, helping biotech and pharmaceutical companies to optimise their clinical research efforts.

EDETEK president Jian Chen said: “EDETEK’s alliance with Medidata underscores our shared vision to enhance clinical research efficiency and efficacy. 

“Together, we will shape a future where real-time, data-driven insights become the bedrock of transformative medical solutions.” 

Last month, Medidata expanded a multi-year deal with Catalyst Clinical Research for clinical trials in the oncology field. 

Under this alliance, Medidata agreed to offer various solutions for the oncology brand of Catalyst Clinical Research, Catalyst Oncology.